共 50 条
Long term outcomes after bariatic and metabolic surgery
被引:6
|作者:
Genser, Laurent
[1
,2
]
Barrat, Christophe
[3
]
机构:
[1] Grp Hosp Pitie Salpetriere, AP HP, Serv Chirurg Hepatobiliopancreat, Transplantat Hepat, F-75013 Paris, France
[2] Grp Hosp Pitie Salpetriere, Inst Cardiometab & Nutr, INSERM, ICAN,UMRS 1166,Equipe Nutr 6, F-75013 Paris, France
[3] Univ Paris XIII, Hop Avicenne, AP HP,Ctr Integre Nord Francilien Obesite, UFR,SMBH,Serv Chirurg Digest & Metabol,Leonard Vi, 125 Rue Stalingrad, F-93000 Bobigny, France
来源:
PRESSE MEDICALE
|
2018年
/
47卷
/
05期
关键词:
LAPAROSCOPIC SLEEVE GASTRECTOMY;
Y GASTRIC BYPASS;
5-YEAR FOLLOW-UP;
MORBID-OBESITY;
5;
WEIGHT-LOSS;
BILIOPANCREATIC DIVERSION;
DUODENAL SWITCH;
SINGLE-CENTER;
OPEN-LABEL;
EXPERIENCE;
D O I:
10.1016/j.lpm.2018.01.003
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
At long (>= 5 years) and very long term (>= 10 years) bariatric and metabolic surgery (BMS) is the only treatment that allows a significant and durable weight loss concomitant with a control of the different obesity related diseases. Regardless of the surgical technique, BMS significantly decrease long-term mortality (-30% at 15 years). The maximum weight loss is reached at postoperative year 2. Beyond, a weight regain and is usually observed in all procedures. The variability of long-term outcomes underlines the importance of multidisciplinary care throughout follow-up. In 2017, Roux-en-Y-gastric bypass and sleeve gastrectomy were the most popular bariatric procedures and seem to have comparable long-term outcomes.
引用
收藏
页码:471 / 479
页数:9
相关论文